Desirée Campoy

Hematologist
Department of Hematology, Hospital Universitari Vall d'Hebron Vall d' Hebron Institut of Oncology (VHIO)
Barcelona, Catalonia, Spain

Presentation(s):

• OC 74.1 - REDUCED DOSE OF RIVAROXABAN/APIXABAN Vs VITAMIN K ANTAGONISTS FOR SECONDARY PREVENTION OF VENOUS THROMBOEMBOLISM: A REAL-WORLD COMPARATIVE STUDY

  Wednesday, June 26, 2024
  10:15 – 10:30 ICT